242 related articles for article (PubMed ID: 33964664)
1. Aspirin and omega-3 fatty acid status interact in the prevention of cardiovascular diseases in Framingham Heart Study.
Block RC; Shearer GC; Holub A; Tu XM; Mousa S; Brenna JT; Harris WS; Tintle N
Prostaglandins Leukot Essent Fatty Acids; 2021 Jun; 169():102283. PubMed ID: 33964664
[TBL] [Abstract][Full Text] [Related]
2. Exploring the association between whole blood Omega-3 Index, DHA, EPA, DHA, AA and n-6 DPA, and depression and self-esteem in adolescents of lower general secondary education.
van der Wurff ISM; von Schacky C; Bergeland T; Leontjevas R; Zeegers MP; Kirschner PA; de Groot RHM
Eur J Nutr; 2019 Jun; 58(4):1429-1439. PubMed ID: 29549496
[TBL] [Abstract][Full Text] [Related]
3. Correlation of omega-3 levels in serum phospholipid from 2053 human blood samples with key fatty acid ratios.
Holub BJ; Wlodek M; Rowe W; Piekarski J
Nutr J; 2009 Dec; 8():58. PubMed ID: 20034401
[TBL] [Abstract][Full Text] [Related]
4. Aspirin and omega-3 polyunsaturated fatty acid use and their interaction in cardiovascular diseases and colorectal adenomas.
Wang IE; Yi S; Block RC; Mousa SA
Nutr Res Rev; 2022 Dec; 35(2):295-307. PubMed ID: 34253265
[TBL] [Abstract][Full Text] [Related]
5. The effects of aspirin on platelet function and lysophosphatidic acids depend on plasma concentrations of EPA and DHA.
Block RC; Abdolahi A; Tu X; Georas SN; Brenna JT; Phipps RP; Lawrence P; Mousa SA
Prostaglandins Leukot Essent Fatty Acids; 2015 May; 96():17-24. PubMed ID: 25555354
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of a unique omega-3 formulation on the correction of nutritional deficiency and its effects on cardiovascular disease risk factors in a randomized controlled VASCAZEN(®) REVEAL Trial.
Shaikh NA; Yantha J; Shaikh S; Rowe W; Laidlaw M; Cockerline C; Ali A; Holub B; Jackowski G
Mol Cell Biochem; 2014 Nov; 396(1-2):9-22. PubMed ID: 25185754
[TBL] [Abstract][Full Text] [Related]
7. Clinical correlates and heritability of erythrocyte eicosapentaenoic and docosahexaenoic acid content in the Framingham Heart Study.
Harris WS; Pottala JV; Lacey SM; Vasan RS; Larson MG; Robins SJ
Atherosclerosis; 2012 Dec; 225(2):425-31. PubMed ID: 22727409
[TBL] [Abstract][Full Text] [Related]
8. The impact of non-surgical periodontal treatment on serum levels of long chain-polyunsaturated fatty acids: a pilot randomized clinical trial.
Martinez GL; Koury JC; Brito F; Fischer RG; Gustafsson A; Figueredo CM
J Periodontal Res; 2014 Apr; 49(2):268-74. PubMed ID: 23721647
[TBL] [Abstract][Full Text] [Related]
9. Effect of APOE Genotype on Plasma Docosahexaenoic Acid (DHA), Eicosapentaenoic Acid, Arachidonic Acid, and Hippocampal Volume in the Alzheimer's Disease Cooperative Study-Sponsored DHA Clinical Trial.
Tomaszewski N; He X; Solomon V; Lee M; Mack WJ; Quinn JF; Braskie MN; Yassine HN
J Alzheimers Dis; 2020; 74(3):975-990. PubMed ID: 32116250
[TBL] [Abstract][Full Text] [Related]
10. Omega-3 polyunsaturated fatty acid biomarkers and risk of type 2 diabetes, cardiovascular disease, cancer, and mortality.
Jiang H; Wang L; Wang D; Yan N; Li C; Wu M; Wang F; Mi B; Chen F; Jia W; Liu X; Lv J; Liu Y; Lin J; Ma L
Clin Nutr; 2022 Aug; 41(8):1798-1807. PubMed ID: 35830775
[TBL] [Abstract][Full Text] [Related]
11. Plasma phospholipid long-chain ω-3 fatty acids and total and cause-specific mortality in older adults: a cohort study.
Mozaffarian D; Lemaitre RN; King IB; Song X; Huang H; Sacks FM; Rimm EB; Wang M; Siscovick DS
Ann Intern Med; 2013 Apr; 158(7):515-25. PubMed ID: 23546563
[TBL] [Abstract][Full Text] [Related]
12. Baseline blood levels of omega-3 and depression remission: a secondary analysis of data from a placebo-controlled trial of omega-3 supplements.
Carney RM; Steinmeyer BC; Freedland KE; Rubin EH; Rich MW; Harris WS
J Clin Psychiatry; 2016 Feb; 77(2):e138-43. PubMed ID: 26930527
[TBL] [Abstract][Full Text] [Related]
13. ω-3 Polyunsaturated Fatty Acid Biomarkers and Coronary Heart Disease: Pooling Project of 19 Cohort Studies.
Del Gobbo LC; Imamura F; Aslibekyan S; Marklund M; Virtanen JK; Wennberg M; Yakoob MY; Chiuve SE; Dela Cruz L; Frazier-Wood AC; Fretts AM; Guallar E; Matsumoto C; Prem K; Tanaka T; Wu JH; Zhou X; Helmer C; Ingelsson E; Yuan JM; Barberger-Gateau P; Campos H; Chaves PH; Djoussé L; Giles GG; Gómez-Aracena J; Hodge AM; Hu FB; Jansson JH; Johansson I; Khaw KT; Koh WP; Lemaitre RN; Lind L; Luben RN; Rimm EB; Risérus U; Samieri C; Franks PW; Siscovick DS; Stampfer M; Steffen LM; Steffen BT; Tsai MY; van Dam RM; Voutilainen S; Willett WC; Woodward M; Mozaffarian D;
JAMA Intern Med; 2016 Aug; 176(8):1155-66. PubMed ID: 27357102
[TBL] [Abstract][Full Text] [Related]
14. Omega-3/omega-6 fatty acid ratios in different phospholipid classes and depressive symptoms in coronary artery disease patients.
Mazereeuw G; Herrmann N; Ma DWL; Hillyer LM; Oh PI; Lanctôt KL
Brain Behav Immun; 2016 Mar; 53():54-58. PubMed ID: 26697998
[TBL] [Abstract][Full Text] [Related]
15. The effect of omega-3 fatty acids on a biomarker of head trauma in NCAA football athletes: a multi-site, non-randomized study.
Heileson JL; Anzalone AJ; Carbuhn AF; Askow AT; Stone JD; Turner SM; Hillyer LM; Ma DWL; Luedke JA; Jagim AR; Oliver JM
J Int Soc Sports Nutr; 2021 Sep; 18(1):65. PubMed ID: 34579748
[TBL] [Abstract][Full Text] [Related]
16. Anger induced by interferon-alpha is moderated by ratio of arachidonic acid to omega-3 fatty acids.
Lotrich FE; Sears B; McNamara RK
J Psychosom Res; 2013 Nov; 75(5):475-83. PubMed ID: 24182638
[TBL] [Abstract][Full Text] [Related]
17. Omega-3 fatty acids, subclinical atherosclerosis, and cardiovascular events: Implications for primary prevention.
Alfaddagh A; Kapoor K; Dardari ZA; Bhatt DL; Budoff MJ; Nasir K; Miller M; Welty FK; Miedema MD; Shapiro MD; Tsai MY; Blumenthal RS; Blaha MJ
Atherosclerosis; 2022 Jul; 353():11-19. PubMed ID: 35759823
[TBL] [Abstract][Full Text] [Related]
18. Increased ω-3 polyunsaturated fatty acid/arachidonic acid ratios and upregulation of signaling mediator in individuals with autism spectrum disorders.
Yui K; Imataka G; Kawasak Y; Yamada H
Life Sci; 2016 Jan; 145():205-12. PubMed ID: 26724495
[TBL] [Abstract][Full Text] [Related]
19. Effects of aspirin in combination with EPA and DHA on HDL-C cholesterol and ApoA1 exchange in individuals with type 2 diabetes mellitus.
Block RC; Holub A; Abdolahi A; Tu XM; Mousa SA; Oda MN
Prostaglandins Leukot Essent Fatty Acids; 2017 Nov; 126():25-31. PubMed ID: 29031392
[TBL] [Abstract][Full Text] [Related]
20. Eicosapentaenoic Acid Versus Docosahexaenoic Acid as Options for Vascular Risk Prevention: A Fish Story.
Singh S; Arora RR; Singh M; Khosla S
Am J Ther; 2016; 23(3):e905-10. PubMed ID: 25828517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
